Volume 76, Issue 11, Pages (December 2009)

Slides:



Advertisements
Similar presentations
Flow chart showing number of citations retrieved by individual searches and number of trials included in review Strippoli GF, et al. BMJ 2008 Feb 25 [Epub.
Advertisements

Susan R. Mendley, Nancy L. Majkowski, Dale A. Schoeller 
From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis Ann Intern Med. 2012;157(4):
LDL cholesterol in CKD—to treat or not to treat?
Volume 55, Issue 4, Pages (April 1999)
Volume 85, Issue 4, Pages (April 2014)
Bias in clinical research
Beta blockers in the management of chronic kidney disease
The overdriven glomerulus as a cardiovascular risk factor
Linear and logistic regression analysis
Marlies Noordzij, Kitty J. Jager  Kidney International 
Anemia management in chronic kidney disease
Volume 85, Issue 4, Pages (April 2014)
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 84, Issue 5, Pages (November 2013)
Volume 64, Issue 6, Pages (December 2003)
Volume 83, Issue 3, Pages (March 2013)
Volume 84, Issue 1, Pages (July 2013)
Confounding: What it is and how to deal with it
Volume 75, Issue 12, Pages (June 2009)
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
The risk of hospitalization and modality failure with home dialysis
John P. Middleton, Patrick H. Pun  Kidney International 
The overdriven glomerulus as a cardiovascular risk factor
Systematic review or meta-analysis
Chapter 3: Management of progression and complications of CKD
Aaron M. Drucker, Patrick Fleming, An-Wen Chan 
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?  Kitty J. Jager, Bengt Lindholm, David Goldsmith, Danilo Fliser,
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Yousef Rezaei, MD  American Journal of Kidney Diseases 
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Susan R. Mendley, Nancy L. Majkowski, Dale A. Schoeller 
This Month in AJKD American Journal of Kidney Diseases
G. Tripepi, K.J. Jager, F.W. Dekker, C. Wanner, C. Zoccali 
Stephen P. McDonald  Kidney International Supplements 
Study of Heart and Renal Protection (SHARP)
Renal Replacement Therapy in Acute Kidney Injury
LDL cholesterol in CKD—to treat or not to treat?
Volume 74, Issue 8, Pages (October 2008)
The analysis of survival data: the Kaplan–Meier method
The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular.
Volume 73, Issue 12, Pages (June 2008)
Volume 76, Issue 6, Pages (September 2009)
Does reducing salt intake increase cardiovascular mortality?
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Alternate-day dialysis may be needed for hemodialysis patients
Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained.
Cardiovascular disease in pediatric chronic dialysis patients
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target    American.
Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.
Neesh Pannu, Braden Manns, Helen Lee, Marcello Tonelli 
A man with a hole in his penis
Prehypertension: is it relevant for nephrologists?
Cardiovascular risk assessment in kidney transplantation
Carmine Zoccali, Francesca Mallamaci  Kidney International 
Volume 72, Issue 2, Pages (July 2007)
The Danish Renal Biopsy Register
Volume 75, Issue 7, Pages (April 2009)
Do meta-analyses in nephrology change the way we treat patients?
The international realities of live donor kidney transplantation
The International Pediatric Peritonitis Registry: Starting to walk
Antioxidant therapy in hemodialysis patients: a systematic review
Where vaptans do and do not fit in the treatment of hyponatremia
Diagnostic methods 2: receiver operating characteristic (ROC) curves
Volume 68, Issue 4, Pages (October 2005)
Sugar-sweetened beverages and chronic disease
Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease 
Presentation transcript:

Volume 76, Issue 11, Pages 1130-1136 (December 2009) Systematic reviews and meta-analyses: when they are useful and when to be careful  Marlies Noordzij, Lotty Hooft, Friedo W. Dekker, Carmine Zoccali, Kitty J. Jager  Kidney International  Volume 76, Issue 11, Pages 1130-1136 (December 2009) DOI: 10.1038/ki.2009.339 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Flow chart showing number of citations retrieved by individual searches and number of trials included in review on the effects of statins in patients with chronic kidney disease. Example reproduced from Strippoli et al.2 with permission from BMJ Publishing Group Ltd. Kidney International 2009 76, 1130-1136DOI: (10.1038/ki.2009.339) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 2 Forest plot showing the effects of statins as compared with placebo or no treatment, on cardiovascular mortality in pre-dialysis, dialysis, and transplant patients. Effects in individual trials are depicted as squares with 95% CIs. Effects of meta-analyses are depicted as diamonds. Example reproduced from Strippoli et al.2 with permission from BMJ Publishing Group Ltd. Kidney International 2009 76, 1130-1136DOI: (10.1038/ki.2009.339) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 3 Funnel plot of the relative risk against the standard error of the logarithm of the relative risk. The relative risk is plotted on a logarithmic scale, so that effects of the same magnitude but opposite direction, for example, 0.5 and 2.0, are equidistant from 1.0. Individual trials are depicted as dots, scattered around the neutral relative risk of 1.0. The relative risks of mortality found in the largest studies were close to 1.0, whereas the smaller trials provided higher relative risks. Visual examination of the funnel plot for publication bias suggests that small trials with negative effects may be underrepresented. Example reproduced from Ho and co-workers26 with permission from BMJ Publishing Group Ltd. Kidney International 2009 76, 1130-1136DOI: (10.1038/ki.2009.339) Copyright © 2009 International Society of Nephrology Terms and Conditions